Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004155183 | SCV003637861 | uncertain significance | not specified | 2022-08-08 | criteria provided, single submitter | clinical testing | The c.920C>T (p.P307L) alteration is located in exon 1 (coding exon 1) of the FBXL17 gene. This alteration results from a C to T substitution at nucleotide position 920, causing the proline (P) at amino acid position 307 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |